๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Efficacy and toxicity of gemtuzumab ozogamicin in patients with acute myeloid leukemia

โœ Scribed by P. L. J. van der Heiden; I. Jedema; R. Willemze; R. M. Y. Barge


Book ID
114793999
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
94 KB
Volume
76
Category
Article
ISSN
0902-4441

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Gemtuzumab ozogamicin in the treatment o
โœ Francis Giles; Elihu Estey; Susan O'Brien ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 484 KB ๐Ÿ‘ 2 views

## Abstract Gemtuzumab ozogamicin (GO) is a chemotherapeutic agent that consists of a humanized antiโ€CD33 antibody (hP67.6) linked to Nโ€acetylโ€ฮณ calicheamicin 1,2โ€dimethyl hydrazine dichloride, a potent enediyne antitumor antibiotic. GO was approved conditionally by the Federal Drug Administration